{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:30:43Z","timestamp":1781634643539,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T00:00:00Z","timestamp":1535068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1038\/s41431-018-0235-y","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T16:43:30Z","timestamp":1535129010000},"page":"494-502","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Clinical utility gene card for: inherited optic neuropathies including next-generation sequencing-based approaches"],"prefix":"10.1038","volume":"27","author":[{"given":"Neringa","family":"Jurkute","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Majander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Votruba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Abbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Acheson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Lenaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Amati-Bonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Moosajee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Arno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Yu-Wai-Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,24]]},"reference":[{"key":"235_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.survophthal.2009.10.002","volume":"55","author":"JA Fraser","year":"2010","unstructured":"Fraser JA, Biousse V, Newman NJ. The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol. 2010;55:299\u2013334.","journal-title":"Surv Ophthalmol"},{"key":"235_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00401-016-1625-2","volume":"132","author":"P Yu-Wai-Man","year":"2016","unstructured":"Yu-Wai-Man P, Votruba M, Burt\u00e9 F, La Morgia C, Barboni P, Carelli V. A neurodegenerative perspective on mitochondrial optic neuropathies. Acta Neuropathol. 2016;132:789\u2013806.","journal-title":"Acta Neuropathol"},{"key":"235_CR3","doi-asserted-by":"publisher","unstructured":"Moosajee M, Yu-Wai-Man P, Rouzier C, Bitner-Glindzicz M, Bowman R. Clinical utility gene card for: Wolfram syndrome. Eur J Hum Genet. 2016. \n                    https:\/\/doi.org\/10.1038\/ejhg.2016.49\n                    \n                  .","DOI":"10.1038\/ejhg.2016.49"},{"key":"235_CR4","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/humu.22307","volume":"34","author":"S Tang","year":"2013","unstructured":"Tang S, Wang J, Zhang VW, et al. Transition to next generation analysis of the whole mitochondrial genome: a summary of molecular defects. Hum Mutat. 2013;34:882\u201393.","journal-title":"Hum Mutat"},{"key":"235_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1089\/gte.2005.9.190","volume":"9","author":"HE White","year":"2005","unstructured":"White HE, Durston VJ, Seller A, Fratter C, Harvey JF, Cross NC. Accurate detection and quantitation of heteroplasmic mitochondrial point mutations by pyrosequencing. Genet Test. 2005;9:190\u20139.","journal-title":"Genet Test"},{"key":"235_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","volume":"30","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies\u2014disease mechanisms and therapeutic strategies. Prog Retin Eye Res. 2011;30:81\u2013114.","journal-title":"Prog Retin Eye Res"},{"key":"235_CR7","first-page":"29","volume":"3","author":"NJ Bergen Van","year":"2011","unstructured":"Van Bergen NJ, Chakrabarti R, O\u2019Neill EC, Crowston JG, Trounce IA. Mitochondrial disorders and the eye. Eye Brain. 2011;3:29\u201347.","journal-title":"Eye Brain"},{"key":"235_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11940-010-0100-y","volume":"13","author":"AA Sadun","year":"2011","unstructured":"Sadun AA, La Morgia C, Carelli V. Leber\u2019s hereditary optic neuropathy. Curr Treat Options Neurol. 2011;13:109\u201317.","journal-title":"Curr Treat Options Neurol"},{"key":"235_CR9","doi-asserted-by":"publisher","unstructured":"Ueda K, Morizane Y, Shiraga F, et al. Nationwide epidemiological survey of Leber hereditary optic neuropathy in Japan. J Epidemiol. 2017. \n                    https:\/\/doi.org\/10.1016\/j.je.2017.02.001\n                    \n                  .","DOI":"10.1016\/j.je.2017.02.001"},{"key":"235_CR10","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/j.ophtha.2013.04.022","volume":"120","author":"P Yu-Wai-Man","year":"2013","unstructured":"Yu-Wai-Man P, Chinnery PF. Dominant optic atrophy: novel OPA1 mutations and revised prevalence estimates. Ophthalmology. 2013;120:1712\u20131712.e1.","journal-title":"Ophthalmology"},{"key":"235_CR11","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.ophtha.2009.12.038","volume":"117","author":"P Yu-Wai-Man","year":"2010","unstructured":"Yu-Wai-Man P, Griffiths PG, Burke A, et al. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. Ophthalmology. 2010;117:1538\u201346.","journal-title":"Ophthalmology"},{"key":"235_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/gim.2014.172","volume":"17","author":"MB Consugar","year":"2015","unstructured":"Consugar MB, Navarro-Gomez D, Place EM, Bujakowska KM, Sousa ME. Panel-based genetic diagnostic testing for inherited eye diseases is highly accurate and reproducible, and more sensitive for variant detection, than exome sequencing. Genet Med. 2015;17:253\u201361.","journal-title":"Genet Med"},{"key":"235_CR13","unstructured":"Yu-Wai-Man P, Chinnery PF. Leber hereditary optic neuropathy. Seattle: University of Washington; 1993."},{"key":"235_CR14","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1167\/iovs.08-3166","volume":"50","author":"MA Kirkman","year":"2009","unstructured":"Kirkman MA, Korsten A, Leonhardt M, et al. Quality of life in patients with leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2009;50:3112\u20135.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"235_CR15","doi-asserted-by":"publisher","unstructured":"Majander A, Bowman R, Poulton J, et al. Childhood-onset Leber hereditary optic neuropathy. Br J Ophthalmol. 2017. \n                    https:\/\/doi.org\/10.1136\/bjophthalmol-2016-310072\n                    \n                  .","DOI":"10.1136\/bjophthalmol-2016-310072"},{"key":"235_CR16","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/humu.21025","volume":"30","author":"M Ferre","year":"2009","unstructured":"Ferre M, Bonneau D, Milea D, et al. Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations. Hum Mutat. 2009;30:692\u2013705.","journal-title":"Hum Mutat"},{"key":"235_CR17","first-page":"21587","volume":"55","author":"P Barboni","year":"2016","unstructured":"Barboni P, Savini G, Valentino ML, et al. Mutation screening of mitochondrial DNA as well as OPA1 and OPA3 in a Chinese cohort with suspected hereditary optic atrophy. Ophthalmology. 2016;55:21587.","journal-title":"Ophthalmology"},{"key":"235_CR18","doi-asserted-by":"publisher","first-page":"e0170090","DOI":"10.1371\/journal.pone.0170090","volume":"12","author":"Y Li","year":"2017","unstructured":"Li Y, Li J, Jia X, Xiao X, Li S, Guo X. Genetic and clinical analyses of DOA and LHON in 304 Chinese patients with suspected childhood-onset hereditary optic neuropathy. PLoS ONE. 2017;12:e0170090. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0170090\n                    \n                  .","journal-title":"PLoS ONE"},{"key":"235_CR19","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ajhg.2008.07.004","volume":"83","author":"HR Elliott","year":"2008","unstructured":"Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet. 2008;83:254\u201360.","journal-title":"Am J Hum Genet"},{"key":"235_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ophtha.2009.07.026","volume":"117","author":"P Barboni","year":"2010","unstructured":"Barboni P, Carbonelli M, Savini G, et al. Natural history of Leber\u2019s hereditary optic neuropathy: longitudinal analysis of the retinal nerve fiber layer by optical coherence tomography. Ophthalmology. 2010;117:623\u20137.","journal-title":"Ophthalmology"},{"key":"235_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ophtha.2004.09.033","volume":"112","author":"G Savini","year":"2005","unstructured":"Savini G, Barboni P, Valentino ML, et al. Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber\u2019s hereditary optic neuropathy mutations. Ophthalmology. 2005;112:127\u201331.","journal-title":"Ophthalmology"},{"key":"235_CR22","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/eye.2011.2","volume":"25","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man P, Bailie M, Atawan A, Chinnery PF, Griffiths PG. *DOA* pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations. Eye. 2011;25:596\u2013602.","journal-title":"Eye"},{"key":"235_CR23","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.ophtha.2016.01.007","volume":"123","author":"A Majander","year":"2016","unstructured":"Majander A, Bitner-Glindzicz M, Chan CM, et al. Lamination of the outer plexiform layer in optic atrophy caused by dominant WFS1 mutations. Ophthalmology. 2016;123:1624\u20136.","journal-title":"Ophthalmology"},{"key":"235_CR24","doi-asserted-by":"publisher","unstructured":"Majander A, Robson AG, Joao C, et al. The pattern of retinal ganglion cell dysfunction in Leber hereditary optic neuropathy. Mitochondrion. 2017. \n                    https:\/\/doi.org\/10.1016\/j.mito.2017.07.006\n                    \n                  .","DOI":"10.1016\/j.mito.2017.07.006"},{"key":"235_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1023\/A:1001844021014","volume":"95","author":"GE Holder","year":"1998","unstructured":"Holder GE, Votruba M, Carter AC, Bhattacharya SS, Fitzke FW, Moore AT. Electrophysiological findings in dominant optic atrophy (DOA) linking to the OPA1 locus on chromosome 3q 28-qter. Doc Ophthalmol. 1998;95:217\u201328.","journal-title":"Doc Ophthalmol"},{"key":"235_CR26","doi-asserted-by":"publisher","unstructured":"Carelli V, Carbonelli M, de Coo IF, et al. International consensus statement on the clinical and therapeutic management of Leber\u02bcs hereditary optic neuropathy. J Neuro Ophthalmology. 2017. \n                    https:\/\/doi.org\/10.1097\/WNO.0000000000000570\n                    \n                  .","DOI":"10.1097\/WNO.0000000000000570"},{"key":"235_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/srep21587","volume":"6","author":"X Wan","year":"2016","unstructured":"Wan X, Pei H, Zhao MJ, et al. Efficacy and safety of rAAV2-ND4 treatment for Leber\u2019s Hereditary optic neuropathy. Sci Rep. 2016;6:21587.","journal-title":"Sci Rep"},{"key":"235_CR28","first-page":"1","volume":"132","author":"RD Koilkonda","year":"2014","unstructured":"Koilkonda RD, Yu H, Chou TH, et al. Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial. JAMA Opthalmology. 2014;132:1\u201322.","journal-title":"JAMA Opthalmology"},{"key":"235_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ana.20175","volume":"56","author":"X Qi","year":"2004","unstructured":"Qi X, Lewin AS, Sun L, Hauswirth WW, Guy J. SOD2 gene transfer protects against optic neuropathy induced by deficiency of complex I. Ann Neurol. 2004;56:182\u201391.","journal-title":"Ann Neurol"},{"key":"235_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ajhg.2008.08.013","volume":"83","author":"S Ellouze","year":"2008","unstructured":"Ellouze S, Augustin S, Bouaita A, et al. Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction. Am J Hum Genet. 2008;83:373\u201387.","journal-title":"Am J Hum Genet"},{"key":"235_CR31","doi-asserted-by":"publisher","unstructured":"Vignal C, Uretsky S, Fitoussi S, et al. Safety of rAAV2\/2-ND4 gene therapy for Leber Hereditary optic neuropathy. Ophthalmology. 2018. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2017.12.036\n                    \n                  .","DOI":"10.1016\/j.ophtha.2017.12.036"},{"key":"235_CR32","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.ophtha.2017.05.016","volume":"124","author":"J Guy","year":"2017","unstructured":"Guy J, Feuer WJ, Davis JL, et al. Gene therapy for Leber hereditary optic neuropathy: low- and medium-dose visual results. Ophthalmology. 2017;124:1621\u201334.","journal-title":"Ophthalmology"},{"key":"235_CR33","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/ICU.0000000000000212","volume":"26","author":"JH Peragallo","year":"2016","unstructured":"Peragallo JH, Newman NJ. Is there treatment for Leber hereditary optic neuropathy? Curr Opin Ophthalmol. 2016;26:450\u20137.","journal-title":"Curr Opin Ophthalmol"},{"key":"235_CR34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/eye.2014.37","volume":"28","author":"P Yu-Wai-Man","year":"2014","unstructured":"Yu-Wai-Man P, Votruba M, Moore AT, Chinnery PF. Treatment strategies for inherited optic neuropathies: past, present and future. Eye. 2014;28:521\u201337.","journal-title":"Eye"},{"key":"235_CR35","doi-asserted-by":"publisher","unstructured":"Poulton J, Finsterer J, Yu-Wai-Man P. Erratum to: Genetic Counselling for Maternally Inherited Mitochondrial Disorders (Molecular Diagnosis & Therapy, (2017), 21, 4, (419\u201329), \n                    https:\/\/doi.org\/10.1007\/s40291-017-0279-7\n                    \n                  ). Mol Diagn Ther. 2017;21:465\u20136. \n                    https:\/\/doi.org\/10.1007\/s40291-017-0286-8\n                    \n                  .","DOI":"10.1007\/s40291-017-0279-7"},{"key":"235_CR36","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s40291-017-0279-7","volume":"21","author":"J Poulton","year":"2017","unstructured":"Poulton J, Finsterer J, Yu-Wai-Man P. Genetic counselling for maternally inherited mitochondrial disorders. Mol Diagn Ther. 2017;21:419\u201329.","journal-title":"Mol Diagn Ther"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0235-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0235-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0235-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T20:58:22Z","timestamp":1684616302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-018-0235-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,24]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["235"],"URL":"https:\/\/doi.org\/10.1038\/s41431-018-0235-y","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,24]]},"assertion":[{"value":"14 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}